The risk of autoimmunity associated with tumor immunotherapy.
Gilboa
E
E
Duke University, Experimental Surgery, Box 2601 Medical Center, Durham, NC 27710, USA. e.gilboa@cgct.duke.edu
D000951:Antigens, Neoplasm / Q000627:therapeutic use; D001324:Autoantigens / Q000276:immunology; D001327:Autoimmune Diseases / Q000276:immunology*; D015551:Autoimmunity; D019496:Cancer Vaccines; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000628:therapy*; D017634:Self Tolerance; D013601:T-Lymphocytes / Q000276:immunology
D000951:Antigens, Neoplasm; D001324:Autoantigens; D019496:Cancer Vaccines